Publikationen, an denen er mitarbeitet ANDRÉS SÁNCHEZ PERNAUTE (10)

2010

  1. MMP-7 and SGCE as distinctive molecular factors in sporadic colorectal cancers from the mutator phenotype pathway

    International Journal of Oncology, Vol. 36, Núm. 5, pp. 1209-1215

2007

  1. Pathological complete response following docetaxel-based neoadjuvant chemotherapy for locally advanced gastric adenocarcinoma

    Clinical and Translational Oncology, Vol. 9, Núm. 5, pp. 335-338

2006

  1. Correlations of telomere length, telomerase activity, and telomerlc-repeat binding factor 1 expression in colorectal carcinoma: Prognostic indications

    Cancer, Vol. 106, Núm. 3, pp. 541-551

2005

  1. Characterization of MDGA1, a novel human glycosylphosphatidylinositol- anchored protein localized in lipid rafts

    Experimental Cell Research, Vol. 307, Núm. 1, pp. 91-99

  2. Clinical relevance of MMP-9, MMP-2, TIMP-1 and TIMP-2 in colorectal cancer

    Oncology Reports, Vol. 13, Núm. 1, pp. 115-120

2004

  1. Differential impact of p16 inactivation by promoter methylation in non-small cell lung and colorectal cancer: clinical implications.

    International journal of oncology, Vol. 24, Núm. 2, pp. 349-355

  2. Relationship between 3p deletions and telomerase activity in non-small-cell lung cancer: Prognostic implications

    British Journal of Cancer, Vol. 90, Núm. 10, pp. 1983-1988

2002

  1. Cooperative role of telomerase activity and p16 expression in the prognosis of non-small-cell lung cancer

    Journal of Clinical Oncology, Vol. 20, Núm. 1, pp. 254-262

  2. Genomic organization of a novel glycosylphosphatidylinositol MAM gene expressed in human tissues and tumors

    Oncogene, Vol. 21, Núm. 19, pp. 3089-3094

  3. Stromelysin-1 promoter mutations impair gelatinase B activation in high microsatellite instability sporadic colorectal tumors

    Cancer Research, Vol. 62, Núm. 13, pp. 3855-3860